Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy.
Soong June BaeSung-Gwe AhnJung Hwan JiChih Hao ChuDooreh KimJanghee LeeSo Eun ParkChihwan ChaJoon JeongPublished in: Journal of breast cancer (2022)
were significantly associated with the prognosis of patients with breast cancer who received neoadjuvant chemotherapy. These results suggest that metabolic non-responders with defective immune systems have worse survival outcomes.